286 related articles for article (PubMed ID: 17761030)
1. Fibrin monomer complex in normal pregnant women: a potential thrombotic marker in pregnancy.
Onishi H; Kaniyu K; Iwashita M; Tanaka A; Watanabe T
Ann Clin Biochem; 2007 Sep; 44(Pt 5):449-54. PubMed ID: 17761030
[TBL] [Abstract][Full Text] [Related]
2. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
Bombeli T; Raddatz-Mueller P; Fehr J
Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
[TBL] [Abstract][Full Text] [Related]
3. [Perioperative changes of the coagulation markers in patients undergoing hip fracture surgery].
Okamura K; Nakagawa I; Hidaka S; Okada Y; Kubo T; Kato T
Masui; 2007 Nov; 56(11):1353-7. PubMed ID: 18027607
[TBL] [Abstract][Full Text] [Related]
4. [Coagulation and fibrinolysis in pregnancy].
Yuasa S; Ishizawa M; Yuki Y; Minoura T; Fujita N; Takahashi H; Yoshimura M; Yamamoto T; Okada H
Rinsho Byori; 1992 Dec; 40(12):1287-91. PubMed ID: 1284915
[TBL] [Abstract][Full Text] [Related]
5. [Usefulness of prothrombin fragment 1 + 2 and fibrin dimer in the detection of hypercoagulation in obstetrical patients with thrombosis risk factors].
Romero-García F; Angulo-Vázquez J; Hernández-Montiel JL; Luna-Zaizar H; de la Torre-Torres S
Ginecol Obstet Mex; 1998 Nov; 66():456-61. PubMed ID: 9823703
[TBL] [Abstract][Full Text] [Related]
6. Soluble fibrin monomer degradation products as a potentially useful marker for hypercoagulable states with accelerated fibrinolysis.
Ieko M; Nakabayashi T; Tarumi T; Naito S; Yoshida M; Kanazawa K; Mizukami K; Koike T
Clin Chim Acta; 2007; 386(1-2):38-45. PubMed ID: 17803984
[TBL] [Abstract][Full Text] [Related]
7. [Pre- and postpartum hemostatic characteristics in pregnancy-related hypertension and pre-eclampsia in comparison with normotensive pregnancies].
Hofmann M; Casper F; Prellwitz W; Brockerhoff P
Z Geburtshilfe Neonatol; 1996; 200(3):104-8. PubMed ID: 8963881
[TBL] [Abstract][Full Text] [Related]
8. Relevance of markers of hemostasis activation in obstetrics/gynecology and pediatrics.
Dati F; Pelzer H; Wagner C
Semin Thromb Hemost; 1998; 24(5):443-8. PubMed ID: 9834011
[TBL] [Abstract][Full Text] [Related]
9. The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial.
Abou-Nassar K; Kovacs MJ; Kahn SR; Wells P; Doucette S; Ramsay T; Clement AM; Khurana R; Mackinnon K; Blostein M; Solymoss S; Kingdom J; Sermer M; Rey E; Rodger M;
Thromb Haemost; 2007 Jul; 98(1):163-71. PubMed ID: 17598009
[TBL] [Abstract][Full Text] [Related]
10. [A trial of setting of the reference intervals of thrombin antithrombin III complex and fibrin.fibrinogen degradation products in pregnant women].
Shizuka R; Amagai H; Kojima J; Imaizumi S; Fukumura Y; Kobayashi I; Takagi T; Ibuki Y
Rinsho Byori; 1994 Nov; 42(11):1194-8. PubMed ID: 7844893
[TBL] [Abstract][Full Text] [Related]
11. Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.
Parolari A; Colli S; Mussoni L; Eligini S; Naliato M; Wang X; Gandini S; Tremoli E; Biglioli P; Alamanni F
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):336-43. PubMed ID: 12579103
[TBL] [Abstract][Full Text] [Related]
12. The effect of prophylactic heparin treatment on enhanced thrombin generation in pregnancy.
Bremme K; Lind H; Blombäck M
Obstet Gynecol; 1993 Jan; 81(1):78-83. PubMed ID: 8416465
[TBL] [Abstract][Full Text] [Related]
13. Detection of decreased response to activated protein C during pregnancy by an endogenous thrombin potential-based assay.
Sugimura M; Kobayashi T; Kanayama N; Terao T
Semin Thromb Hemost; 1999; 25(5):497-502. PubMed ID: 10625209
[TBL] [Abstract][Full Text] [Related]
14. D-dimers, thrombin-antithrombin complexes, and risk factors for thromboembolism in hospitalized patient.
Pottier P; Fouassier M; Hardouin JB; Volteau C; Planchon B
Clin Appl Thromb Hemost; 2009 Dec; 15(6):666-75. PubMed ID: 18796458
[TBL] [Abstract][Full Text] [Related]
15. Comparison of markers of coagulation activation and thrombin generation test in uncomplicated pregnancies.
Joly B; Barbay V; Borg JY; Le Cam-Duchez V
Thromb Res; 2013 Sep; 132(3):386-91. PubMed ID: 23962423
[TBL] [Abstract][Full Text] [Related]
16. Elevated fibrin-related markers in patients with malignant diseases suspected of having thrombotic disorders.
Nomura H; Wada H; Mizuno T; Yamashita Y; Saito K; Kitano S; Katayama N; Yamada N; Sugiyama T; Sudo A; Usui M; Isaji S; Nobori T
Clin Appl Thromb Hemost; 2010 Jun; 16(3):266-72. PubMed ID: 19648145
[TBL] [Abstract][Full Text] [Related]
17. Changes in molecular markers of hemostatic and fibrinolytic activation under various sampling conditions using vacuum tube samples from healthy volunteers.
Omote M; Asakura H; Takamichi S; Shibayama M; Yoshida T; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Nakao S; Wada T
Thromb Res; 2008; 123(2):390-5. PubMed ID: 18579183
[TBL] [Abstract][Full Text] [Related]
18. Use of the fibrin D-dimer in screening for coagulation abnormalities in preeclampsia.
Trofatter KF; Howell ML; Greenberg CS; Hage ML
Obstet Gynecol; 1989 Mar; 73(3 Pt 1):435-40. PubMed ID: 2915868
[TBL] [Abstract][Full Text] [Related]
19. Venous thromboembolism in obstetrics and gynecology.
Krivak TC; Zorn KK
Obstet Gynecol; 2007 Mar; 109(3):761-77. PubMed ID: 17329532
[TBL] [Abstract][Full Text] [Related]
20. D-dimer testing in pregnancy.
Eichinger S
Semin Vasc Med; 2005 Nov; 5(4):375-8. PubMed ID: 16302159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
